Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessBuy BPCL, India Cements, UPL; Aurobindo Pharma may hit Rs 700: Ashwani Gujral

    Buy BPCL, India Cements, UPL; Aurobindo Pharma may hit Rs 700: Ashwani Gujral

    According to Ashwani Gujral of ashwanigujral.com, one can buy BPCL, India Cements and UPL and feels that Aurobindo Pharma may test Rs 700.

    June 16, 2017 / 11:52 IST

    Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "Aurobindo Pharma is going through a sharp rally and Rs 700 is the 200-day moving average, so, that is a nice target. It is possible that it has bottomed out but possibly a correction from Rs 700 will tell us whether that has happened. So, I would think that a target of Rs 700 should be likely on Aurobindo Pharma."

    "India Cements is a buy with a stop loss of Rs 212 and target of Rs 226. UPL is also a buy with a stop loss of Rs 865 and target of Rs 900. BPCL yesterday was at its 200-day moving average. So, today’s upside has a very close stop. That is often good for traders. BPCL is a buy with a stop losss of Rs 680 and target of Rs 705," he said.

    first published: Jun 16, 2017 11:50 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347